Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 6203-6205

  Liu, Jiajia ^a   Akahosh, Tohru ^a   Sasahana, Takeshi ^a   Kitasato, Hidero ^a   Namai, Rie ^a   Sasaki, Takeji ^a   Inoue, Matsuhisa ^a   Kondo, Hirobumi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN KINASE C INHIBITOR; VEROTOXIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0032726372     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.6203-6205.1999     Document Type: Article

References (22)

1. Argyle, J. C., R. T. Hogg, T. J. Pysher, F. G. Silva, and R. L. Siegler. 1990. A clinicopathological study of 24 children with hemolytic uremic syndrome. Pediatr. Nephrol. 4:52-58.
2. Brach, M. A., S. deVos, H.-J. Gruss, and F. Hermann. 1992. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920-2924.
3. Chandra, B., C. Louis, and T. Obrig. 1995. Specific interaction of E. coli O157:H7-derived Shiga-like toxin 2 with human renal endothelial cells. J. Infect. Dis. 172:1397-1401.
4. Forsyth, K. D., A. C. Simpson, M. M. Fitzpatrick, T. M. Barratt, and R. J. Levinsky. 1989. Neutrophil-mediated endothelial injury in haemolytic uremic syndrome. Lancet ii:411-414.
5. Habib, R., M. Levy, M. F. Gagnadoux, and M. Broyer. 1982. Prognosis of the hemolytic uremic syndrome in children. Adv. Nephrol. 11:99-128.
6. Inward, C. D., J. Willias, I. Chant, J. Crocker, D. V. Milford, P. E. Rose, and C. M. Taylar. 1995. Verotoxin-1 induces apoptosis in vero cells. J. Infect. 30:213-218.
7. Jackson, M. P., R. J. Neill, A. D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin 1 and Shiga-like toxin 2 encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:109-114.
8. Konowalchuk, J., J. I. Speirs, and S. Stavric. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18:775-782.
9. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. D. Grandis, and M. A. Karmai. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262: 8834-8843.
10. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
11. Macleod, D. L., and C. L. Gyles. 1990. Purification and characterization of an Escherichia coli Shiga-like toxin 2 variant. Infect. Immun. 18:775-779.
12. Mahan, J. D., C. McAllister, and M. Karmali. 1996. Verotoxin-1 induction of apoptosis in human glomerular capillary endothelial cells (GCEC) in vitro is dependent on cytokines, cell confluence, and cell cycle. J. Am. Soc. Nephrol. 7:1661.
13. Morigi, M., G. Micheletti, M. Figliuzzi, B. Imberti, M. A. Karmali, A. Remuzzi, and C. Zoja. 1995. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions. Blood 86:4553-4558.
14. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
15. Ottonello, L., R. Gonella, P. Dapino, C. Sacchetti, and F. Dallegri. 1998. Prostaglandin E2 inhibits apoptosis in human neutrophils: role of intracellular cyclic AMP levels. Exp. Hematol. 26:895-902.
16. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity of Shiga-like toxin in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180
17. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Heson, and C. Haslett. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. J. Clin. Investig. 83:865-875.
18. Setten, P. A. V., L. A. H. Monnerns, R. G. G. Verstraten, L. P. W. J. van den Heuvel, and V. W. M. van Hinsbergh. 1996. Effects of verotoxin-1 on non-adherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88:174-183.
19. Strockbine, N. A., L. R. M. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
20. Sweeney, J. F., P. K. Nguyen, G. M. Omann, and D. B. Hinshaw. 1998. Lipopolysaccharide protects polymorphonuclear leukocytes from apoptosis via tyrosine phosphorylation-dependent signal transduction pathways. J. Surg. Res. 74:64-70.
21. Taga, S., K. Carlier, Z. Mishal, C. Capoulade, M. Mangeney, Y. Lecluse, D. Coulaud, C. Tetaud, L. L. Pritchard, T. Tursz, and J. Wiels. 1997. Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood 90:2757-2767.
22. Tesh, V. L., B. Ramegowda, and J. E. Samuel. 1994 Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62:5085-5094.